Advances:
- Cerevel Therapeutics (CERE) +102.4%. CERE said its Phase I-B study for its schizophrenia treatment yielded positive results.
- Enerpac Tool (EPAC) +6.9%. EPAC's third-quarter results beat estimates.
- 2U (TWOU) +5.5%. TWOU will acquire edX's assets for $800 million.
Declines:
- Herman Miller (MLHR) -6.3%. MLHR's fourth-quarter backlog disappointed.
- Fox (FOXA) -2.9%. FOXA shares were downgraded from "buy" to "neutral" at Guggenheim.
- Carvana (CVNA) -2.3%. CVNA shares were downgraded from "overweight" to "neutral" at Piper Sandler.